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Eﬃcient osteogenetic diﬀerentiation and bone formation from muscle-derived stem cells (MDSCs) should have potential clinical
applications in treating nonunion fracture healing or bone defects. Here, we investigate osteogenetic diﬀerentiation ability of
MDSCs induced by bone morphogenetic protein 9 (BMP9) in vitro and bone formation ability in rabbit radius defects repairing
model. Rabbit’s MDSCs were extracted by type I collagenase and trypsin methods, and BMP9 was introduced into MDSCs by
infection with recombinant adenovirus. Eﬀects of BMP9-induced osteogenetic diﬀerentiation of MDSCs were identiﬁed with
alkaline phosphatase (ALP) activity and expression of later marker. In stem-cell implantation assay, MDSCs have also shown
valuable potential bone formation ability induced by BMP9 in rabbit radius defects repairing test. Taken together, our ﬁndings
suggest that MDSCs are potentiated osteogenetic stem cells which can be induced by BMP9 to treat large segmental bone defects,
nonunion fracture, and/or osteoporotic fracture.
1.Introduction
Skeletal muscles are always regarded as the source of satellite
stem cells or muscle precursor cells. These kinds of stem cells
are at the quiescent condition under normal circumstances
and activated when the repairing of muscle tissue is needed.
They will be diﬀerentiated and blended together into new
muscle ﬁbers, reaching the purpose of repairing defected
muscles as a result [1]. In recent years, studies have shown
that there is also another kind of stem cells in skeletal
muscle, called muscle-derived stem cells (MDSCs). They
have mesenchymal stem cells-like diﬀerentiation potential
[2], and the ability of being diﬀerentiated into several types
ofterminalcellsismaintained.Insteadofbeingdiﬀerentiated
intomusclecells,MDSCscanalsobediﬀerentiatedintoother
type of cells, such as hematopoietic cells [3], osteoblasts
[4], and chondroblasts [5] under particular conditions.
Therefore, the potential of MDSCs as candidate seed cells
in osteogenetic tissue engineering has been paid much more
attention than before.
Bone morphogenetic proteins (BMPs) belong to one of
the β-superfamily members of transforming growth factors
(TGFs); BMPs are a kind of multifunctional growth factors
and are one of the most potent osteogenetic growth factors
[6–8]. BMP9 belongs to BMPs family and is expressed
in liver [9]. BMP9 possible roles include inducing and
maintaining the cholinergic phenotype of embryonic basal
forebrain cholinergic neurons, inhibiting hepatic glucose
production and inducing the expression of key enzymes
of lipid metabolism, and stimulating murine hepcidin 1
expression [10–12]. Although the functional role of BMP9 in
theskeletalsystemremainstobefullyunderstood,thepotent
osteogenic activity of BMP9 suggests that it may be used as
one of the most eﬀective bone regeneration agents compared
with other BMPs, such as BMP2, BMP4, or BMP7 [13, 14].
Presently, among the overwhelming majority of many
osteogeneticstudiesofBMPs,mousemesenchymalstemcells
(such as C3H10), mouse embryonic ﬁbroblasts (MEFs), and
bone marrow stromal cells (BMSCs) are subjected as study-
ing objects. However, there have been no literature reports
on whether BPM9 can induce osteogenetic diﬀerentiation of
muscle-derived stem cells. Therefore, in this paper, we have
demonstrated the potential osteogenetic ability of MDSCs
induced by BMP9 in vitro and in vivo testing.2 Journal of Biomedicine and Biotechnology
2.MaterialsandMethods
2.1. Materials. BMP9, BMP2, and GFP expression aden-
oviruses (AdBMP9, AdBMP2, and Ad-GFP) were provided
by Dr. He (Molecular Oncology Laboratory, Medical Center,
the University of Chicago, USA) and ampliﬁed in our
laboratory. Hank’s solution, DMEM culture medium, and
high-quality fetal calf serum (FBS) were used in cells
culture (Hyclone Company). Alkaline phosphatase (ALP)
staining kit and quantitative testing kit were purchased
from BD Company. Alizarin red S staining kit, type I
collagenase, trypsin, polylysine, and vitamin C were pur-
chased from Sigma Company. Anti-Sca-1 antibody (Wuhan
Boster Biological Technology Co., Ltd.) and nanohydroxya-
patite/polyamide bone cement were provided by Research
Center of Nano-biomaterials, Sichuan University.
Healthy rabbits with an average age of 6–8 weeks, as
the experimental animal, were provided by the Experimental
Animal Center, Chongqing Medical University.
2.2. Methods
2.2.1.SeparationandCultivationofMDSCs. Afteranesthesia,
muscle strips (2cm × 0.8cm × 0.5cm, approximately 5g)
were cut from the rabbits and then placed into a sterilized
bottle. Carry out sequential digestion by two-step method
(type I collagenase and trypsin methods), then ﬁlter through
no. 100, 200, and 400 stainless steel screens, and aspirate
the obtained cells into a 100mL culture bottle (PP1). 9mL
of DMEM culture solution (contained 100mL/L fetal calf
serum) was added. 1h later, transfer the cell suspension
into another culture dish (PP2) by the diﬀerential-rate wall-
adhering growth method. Hereafter, repeat the procedure
above to obtain PP3, PP4, PP5, and PP6 every 24h.
2.2.2. Identiﬁcation of MDSCs. MDSCs were ﬁxed with ace-
tone and prepared for immunohistochemical staining analy-
sis at 48 hours after subculture. Immunohistochemical stain-
ing was subjected with mouse anti-rabbit Sca-1 monoclonal
antibodies.
2.2.3. ALP Staining and ALP Activity Quantitative Measure-
ment. ALP activity was assessed by a modiﬁed Great Escape
SEAP Chemiluminescence Assay (BD Clontech, Mountain
View, CA, USA) and/or histochemical staining assay (using
a mixture of 0.1mg/mL of naphthol AS-MX phosphate and
0.6mg/mL of fast blue BB salt) [13, 14]. Cultured MDSCs
were seeded in 24-well plate with subconﬂuent of 30%
and infected with AdBPM9 (experimental group), AdBPM2
(positive control group), and Ad-GFP (negative control
group), respectively. At 5, 7, and 9 days after infection,
ALP activity would be measured and histochemical staining
would be done as indicated. The results were repeated in
at least three independent experiments. ALP activity was
normalized by total cellular protein concentrations among
the samples.
2.2.4. Calcium Salt Sedimentation Experiment. MDSCs were
seeded into a 24-well plate and infected with AdBPM9,
AdBMP2, and Ad-GFP. Alizarin red S staining was subjected
at 14 days after infection. Cells were ﬁxed with 0.05% (v/v)
glutaraldehyde at room temperature for 10 minutes. After
being washed with distilled water, ﬁxed cells were incubated
with 0.4% alizarin red S (Sigma-Aldrich) for 5 minutes,
followed by extensive washing with distilled water. The
staining of calcium mineral deposits was recorded under
bright-ﬁeld microscopy.
2.2.5.PreparationofBoneDefectModelandAnimalGrouping.
Anesthetize 36 New Zealand white rabbits, then dissection
was cut (longitudinally approximately 30mm along the
inner side of the forearm) to adequately expose the middle
segment of the radius, and prepare a bone defect model
of approximately 12mm by an electric saw, in accordance
with the length of the implant. Randomly assign the rabbits
into 3 groups and implant Adv-hBMP9 + nanohydroxyap-
atite/polyamide bonecement,Adv-hBMP2+nanohydroxya-
patite/polyamide bone cement, and Adv-GFP + hydroxyap-
atite/polyamide bone cement at the left and right bone defect
sites, respectively. Suture the wound layer by layer and wrap
with sterile dressings. After the surgery, each rabbit in each
group is injected with gentamicin sulfate 10,000U, for 3d;
the rabbits of each group are fed in diﬀerent cages.
2.2.6.DetectionbyX-RayRadiography. CarryoutX-ra yradi-
ography in weeks 2, 4, 8, 12, and 16 after the surgery, respec-
tively.
2.2.7. Collection and Detection of Histological Specimens. In
Weeks2,4,6,8,12,and16afterthesurgery,sacriﬁce2rabbits
ofeachgroup,respectively,macroscopicallyobservetheheal-
ing condition of the implant and surrounding tissues, and
carry out a histological examination of the tissue in the stent.
3. Results
3.1. Separation and Cultivation of MDSCs. The cells of early
wall-adheringgrowth(PP1)aremostlyﬁbroblasts,withlarge
body and with rapid growth, without signiﬁcant directional
growth. The cells of late-stage wall-adhering growth (PP6)
aremostlyshort,fusiform,polygonalcells(Figure 1(a)),with
obviously directional growth that may form into a long
chain;however,theirgrowthisslowerthanthatofﬁbroblasts.
In 7–10d later, intercellular lamellar fusion occurs; hereafter,
cell growth rate is slower than before.
3.2. Identiﬁcation of MDSCs. Sca-1 is one of the most char-
acteristic phenotypes of MDSCs; when the in vitro culture
densityofcellsreached70%–80%,Sca-1immunohistochem-
ical staining was carried. The results showed that 80%–90%
of cells were positive in Sca-1 staining (Figure 1(b)).
3.3. ALP Staining and ALP Activity of BMP9 Induced in
Muscle-Derived Stem Cells. ALP is the early marker for
osteogenous diﬀerentiation of cells. ALP staining of MDSCs
transfected with BMP9, BMP2, and GFP at day 9 was shown
(Figure 2(a)). It suggested that ALP expression induced byJournal of Biomedicine and Biotechnology 3
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Figure 1: (a) Culture of muscle-derived stem cells. MDSCs were cultured and subcultured at conﬂuent of 80%. Bright view images were
taken at day 1 and day 5 after subconﬂuent. (b) Immunohistochemical staining of Sca-1. MDSCs were subcultured. Expression of Sca-1 was
assessed by immunohistochemical staining analysis at day 2 using an anti-Sca-1 antibody (Wuhan Boster Biological Technology Co., Ltd.).
BMP9 in MDSCs was higher than other groups. And also,
ALP activities of MDSCs after infected by BMP9, BMP2, and
GFP expression adenovirus were assessed at days 5, 7, and
9( Figure 2(b)). ALP activities induced by BMP9 in MDSCs
were signiﬁcantly higher in indicated time points.
3.4. Expression of BMP9-Induced Calcium Salt Sedimentation
in Muscle-Derived Stem Cells. Alizarin red S staining was
carried out at day 14 after infection; it was found that, under
the induction of BMP9, obvious calcium salt sedimentation
occurred in MDSCs, the density of calciﬁcation was higher
than other groups, and at the same time, the size of
calciﬁcation in BMP9 group was larger (Figure 3).
3.5. Results of X-Ray Radiography. Week 2 after the surgery:
no obvious callus formation was seen around the implant in
each group.
Week 4 after the surgery: the boundary between the
broken ends of bone and the implant was veiled in the BMP9
group, and the transmittancy of the implant was decreased.
No obvious changes occurred in the remaining two groups.
Week 8 after the surgery: callus grew into the implant
from the two broken ends of bone and from the side of the
ulna (Figure 4). The amount of formed callus in the BMP2
group was less than that in the phase in the BMP9 group
(Figure 4). A small amount of callus was seen in the side of
ulna in the GFP group (Figure 4).
Week 12 after the surgery: in the BMP9 group, the two
broken ends of bone were completely connected, and the
majority of bone marrow cavities were recanalized. However,
the two broken ends of bone were not completely connected
in the BMP2 group.
Week 16 after the surgery: in the BMP9 group, the
two broken ends of bone were completely connected, and
the majority of bone marrow cavities were recanalized
(Figure 4). However, the ends of bone broken were not
completely connected in the BMP2 group (Figure 4). In the
GFP group, there was only a certain amount of formed callus
in the side of ulna and in the proximal end of bone broken
(Figure 4).
3.6. Morphologic Macroscopic Observation. W e e k2a f t e rt h e
surgery: in the BMP9 group, the implant was wrapped by
noncohesive ﬁbroustissues, the two ends of the implant were
connected with the recipient bone ﬁbers, a small amount of
soft tissues with blood vessels grew into the lateral aperture
of the implant, no obvious new bone formation was seen,
and the adhesion between the implant and the recipient
bone was not ﬁrm and the implant could be shaken. In the
BMP2 group, it was seen that the implant was wrapped by
noncohesive ﬁbrous tissues, no obvious new bone formation
wasseen,andtheimplantcouldbeshaken.IntheGFPgroup,
it was seen that the implant was wrapped by a small amount
of ﬁbrous tissues.
Week 4 after the surgery:in the BMP9group, the implant
was wrapped by ﬁbrous tissues, the proximal and distal ends
of the implant were connected with the recipient bone and
couldnotbeshaken,alargeamountofsofttissueswithblood4 Journal of Biomedicine and Biotechnology
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Figure 2: Potentiation of BMP-induced early osteogenetic marker
ALP activity in muscle-derived stem cells. (a) ALP staining in
MDSCs. MDSCs were infected with AdBMP9, AdBMP2, and Ad-
GFP. ALP staining was done at the indicated time points. ALP
expression induced by BMP9 in MDSCs was shown higher than
other groups. (b) BMP-induced ALP activity in MDSCs. MDSCs
were infected with AdBMP9, AdBMP2, and Ad-GFP. ALP activity
was measured at the indicated time points. Each assay condition
was dose in triplicate. ALP activities induced by BMP9 in MDSCs
were signiﬁcantly higher in indicated time points (P<0.001).
vessels grew into the lateral aperture of the implant, and
there was a small amount of formed new callus. In the BMP2
group, a small amount of soft tissues with blood vessels grew
into the lateral aperture of the implant, and no new bone
formation was seen. In the GFP group, a small amount of
soft tissues with blood vessels grew into the lateral aperture
of the implant, and no new bone formation was seen.
Week 6 afterthe surgery: in the BMP9group, the implant
waswrappedcompletelybyﬁbrousmembranoustissues,and
therewerehardnewbone andcallusformation. IntheBMP2
group, there was a small amount of formed new callus. In the
GFP group, new bone callus formation occurs initially.
Week 8 after the surgery: in the BMP9 group, there
was a large amount of formed new callus. It was seen that
hard calluses grew into the implant, and a bone-wedge-like
structure was formed in the lateral aperture of the implant.
In the BMP2 group, the lumen was full of connective tissues,
and there was new callus formation. In the GFP group, a
small amount of new callus was formed.
Weeks 12 and 16 after the surgery: in the BMP9 group,
callus was increased. In the BMP2 group, it was seen that
hardcallusesgrewintotheimplant.IntheGFPgroup,alarge
amount of new callus was formed.
3.7. Results of Histological Examination. In the BMP9 group:
in Week 2 after the surgery, it was seen that connective
tissues grew into the lumen of the implant, and there were
much inﬂammatory cell inﬁltration and immature capillary
formation. In week 4 after the surgery, the lumen was full
of connective tissues, inﬂammatory cells were reduced, a
mature vascular net was formed, and it was seen that a
small amount of cartilage grew. In week 6 after the surgery,
a mature vascular net was formed, and there was ﬁbrous
callus formation in the stent. In week 8 after the surgery,
the lumen was full of mature vascular net and cartilages, and
there were much ﬁbrous callus and osteoid formations, and a
bone wedge-like structure was formed in the lateral aperture
of the implant. Some cartilages were directly adhered to the
surfaceoftheimplant(Figure 5).Inweek12afterthesurgery,
the lumen was full of cartilages; after bone formation and
moulding, mature bone trabecular formation was seen, sim-
ilartoperipheralbones,observedundermicroscope,andwas
connected with the recipient bone mutually. In week 16 after
the surgery, the bone cavity was ﬁlled with mature trabecular
bone, and immature trabecular bone between meshes were
connected into mesh-like and plate-like shapes (Figure 5).
In the BPM2 group: vasoformation and bone formation
were similar to those in the BMP9 group; however, the times
for vasoformation and bone formation were approximately 2
weeks later than those in the BMP9 group (Figure 5).
In the GFP group: the times for vasoformation and bone
formation were much later than those in the BMP2 group
(Figure 5).
4. Discussion
There are several classes of cell populations in the skeletal
muscle, of which the muscle-derived stem cells (MDSCs)
have multidirectional diﬀerentiation ability [4, 15–17]. In
the experiment, MDSCs were extracted by the preplate
technique; the principle of this technique was based on
diﬀerent times for wall-adhering growth of diﬀerent cells:
the majority of cells of initial wall-adhering growth are
ﬁbroblasts (PP1), the main portion of cells of wall-adhering
growth in 24–48h are satellite cells (PP2-PP4), and cells
of last wall-adhering growth were Sca-1 staining-positive
MDSCs. Prior to wall-adhering growth, MDSCs were of
smallandroundsphericalshape,withstrongrefractivity,and
were also of round shape at the time of initial wall-adhering
growth;afterspontaneousgrowth,theyarefusedintomature
polynuclear myotubes. It is diﬀerent from ﬁbroblasts in this
point. After MDSCs transfected with BMP9 and BMP2,
it is found by ALP staining and quantitative analysis that
BMP9 induced ALP activities of muscle-derived stem cells,
and the activities were increased with time, reaching peak
in day 9, suggesting that MDSCs had the osteogenous
diﬀerentiation ability in vitro. Meanwhile, the ALP activities
induced by BMP9 were obviously higher than those in the
BMP2 group, suggesting that BMP9 had higher potential
ability of osteogenesis stimulating than BMP2. The resultsJournal of Biomedicine and Biotechnology 5
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Figure 3: Alizarin red S staining. MDSCs were infected with adenoviruses as indicated. Alizarin red S staining was conducted at 14 days.
The density of calciﬁcation induced by BMP9 was higher than other groups, and at the same time, the size of calciﬁcation in BMP9 group
was larger.
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Figure 4:BoneformationofMDSCsinducedbyBMP2andBMP9inrabbitradiusdefectsrepairingtest.BMP9orBMP2expressionMDSCs
were implanted in rabbit radius defects model. X-ray images of bone formation by MDSCs implantation assay had been taken at week 8 and
week 16. Representative X-ray images are shown as indicated.
of the later-stage marker, that is, calcium salt sedimentation,
for osteogenous diﬀerentiation of cells showed that there
was obvious calcium salt sedimentation in the BMP9 group;
moreover, compared with that in the BMP2 group, BMP9
hasstrongerabilityofstimulatingcalciumsaltsedimentation
in MDSCs. These demonstrated that BMP9 was probably
am o r ee ﬃcient osteoinductive growth factor compared with
BMP2. The result was consistent with that from the studies
conducted by Wada et al. [18].
Previously, the studies by D. S. Musgrave found that,
under the action of BMP2, MDSCs resulted in ectopic
osteogenesis in upper limbs [19]. In the studies by V. Wright,6 Journal of Biomedicine and Biotechnology
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Figure 5: Histologic evaluation of the retrieved bone samples. Retrieved bone sample from BMP9- or BMP2-treated groups were ﬁxed and
decalciﬁed. The paraﬃn-embedded sections was subjected to hematoxylin and eosine (H&E) staining. Representative images are shown.
Magniﬁcation, 200.
MDSCstransfectedwithBMP4-inducedectopicosteogenesis
a n dp r o m o t e db o n eh e a l i n g[ 20]. Therefore, during our
study, the eﬀects of BMP9/2/GFP in repairing radius defect
were observed by using the method in which, after the
middle segment defect model of radius was prepared,
Adv-hBMP9/2/GFP + nanohydroxyapatite/polyamide bone
cement was implanted. As a result, new bone was initially
emerged in week 4 in the BMP9 group; in the BMP9 group,
by week 8, large mounts of blood vessels, soft tissues, and
bone calluses were formed, and hard calluses grew into
the implant. In week 16 after the surgery, the two broken
ends of bone were completely connected, and the majority
of bone marrow cavities were recanalized; by histological
examination, mature bone trabecular was seen, and new
bone trabecular between meshes was connected into mesh-
like and plate-like shapes. The repairing duration of bone
defectsintheBMP2groupwasapproximately2weekslonger
than that in the BMP9 Group. Bone defects repairing in GFP
group is much more slow than that in the BMP2 group.
This result is consistent with the prior reports submitted by
Cheng et al. [13] and Kang et al. [14]. They demonstrated
that BMP9 (in addition to BMP-2, BMP4, or BMP-7) is
identiﬁed as the most potent BMPs to induce orthotopic
bone formation in vivo [14].
From what have been discussed above, BMP9 has strong
eﬀects of inducing directional osteogenous diﬀerentiation of
muscle-derived stem cells; compared with other stem cells
in tissue engineering, the in vitro cultivation of MDSCs
has the advantages of good material availability, as well as
strong proliferation and diﬀerentiation abilities. Meanwhile,
it has also demonstrated that it is a research direction of vast
potential to carry out research on artiﬁcial bone in tissue
engineering, by using highly eﬃcient osteogenous induction
factor and readily available, adequate tissue stem cells in
combination.
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